Results 51 to 60 of about 66,784,034 (314)

COVID-19: Vaccines and therapeutics

Bioorganic & Medicinal Chemistry Letters, 2022
Coronavirus disease 2019 (COVID-19) is a communicable disease triggered by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged as leading cause of death from a single infectious agent globally. Despite of rigorous protective measures, availability of multiple vaccines and with few approved therapeutics, the virus effect on the ...
Ponnampalli, Swapna, Venkata Suryanarayana Birudukota, Naga, Kamal, Ahmed   +2 more
openaire   +2 more sources

COVID-19 vaccination passports [PDF]

Science, 2021
As countries grow eager to reignite their economies and people increasingly yearn for mobility and normalcy in life, pressure is mounting for some form of COVID-19 health status certificate that would support these desires. There has already been an explosion of COVID-19 passport initiatives for domestic use and international travel.
Dye, C, Mills, MC
openaire   +2 more sources

Motivation to Have COVID-19 Vaccination Explained Using an Extended Protection Motivation Theory among University Students in China: The Role of Information Sources

Vaccines, 2021
Background: The aims of the present study were to examine the prediction of the threat and coping appraisal utilizing an extended protection motivation theory (PMT) for the motivation to have COVID-19 vaccination and the influence of various information ...
Peng-Wei Wang, Daniel Kwasi Ahorsu, Chung-Ying Lin, I-Hua Chen, Cheng-Fang Yen, Yi-Jie Kuo, Mark D. Griffiths, Amir H. Pakpour   +7 more
doaj   +1 more source

Covid-19 vaccination hesitancy [PDF]

BMJ, 2021
### What you need to know Rollout of covid-19 vaccination is well underway, with more than 700 million doses given worldwide as of April 2021.1 Vaccination is highly effective at reducing severe illness and death from covid-19. Vaccines for covid-19 are also safe, with extremely low risks of severe adverse events.234 A major threat to the impact of ...
Razai, MS, Chaudhry, UAR, Doerholt, K, Bauld, L, Majeed, A   +4 more
openaire   +3 more sources

COVID-19 Vaccination in Young People with Functional Neurological Disorder: A Case-Control Study

, 2022
Background: The emergence of acute-onset functional neurological symptoms, the focus of this study, is one of three stress responses related to immunisation.
Russell C. Dale, Joseph Elkadi, Davinder Singh-Grewal, Karen Waters, Kozlowska, Kasia, Kasia Kozlowska, Archana Prasad, Stephen Scher, Elkadi, Joseph, Lim, Natalie, Wood, Nicholas, Dale, Russell C., Prasad, Archana, Natalie Lim, Waters, Karen, Scher, Stephen, Nicholas Wood, Singh-Grewal, Davinder   +17 more
core   +1 more source

Atypical subepidermal blistering disease following COVID‐19 vaccination

Journal of Cutaneous Immunology and Allergy, 2023
Atypical bullous disease after COVID‐19 vaccination.
Noureddine Litaiem, Azza Ghannem, Amal Chabbouh, Soumaya Rammeh, Maryam Sellami, Faten Zeglaoui   +5 more
doaj   +1 more source

A Third Dose COVID-19 Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation Patients

, 2022
We previously reported that a second dose of BNT162b2 was safe and effective for allogeneic hematopoietic stem cell transplantation (HSCT) patients. Here, we investigated the safety and efficacy of a third dose of COVID-19 mRNA vaccine in allogeneic HSCT
Wataru Hojo, Miki Saeki, Tohru Murayama, Saito, Yasuyuki, Funakoshi, Yohei, Hojo, Wataru, Yoshiharu Miyata, Shinichiro Kawamoto, Nagao, Shigeki, Kawamoto, Shinichiro, Yakushijin, Kimikazu, Shigeki Nagao, Yohei Funakoshi, Matsuoka, Hiroshi, Sakuya Matsumoto, Hironobu Minami, Kimikazu Yakushijin, Akihito Kitao, Hiroshi Matsuoka, Goh Ohji, Rina Sakai, Matsumoto, Sakuya, Kitao, Akihito, Ohji, Goh, Saeki, Miki, Hiroya Ichikawa, Watanabe, Marika, Koyama, Taiji, Ito, Mitsuhiro, Katsuya Yamamoto, Yuri Hirakawa, Miyata, Yoshiharu, Yasuyuki Saito, Ichikawa, Hiroya, Murayama, Tohru, Sakai, Rina, Mitsuhiro Ito, Yamamoto, Katsuya, Hironori Sakai, Minami, Hironobu, Marika Watanabe, Sakai, Hironori, Hirakawa, Yuri, Taiji Koyama   +43 more
core   +1 more source

Recombinant vaccines for COVID-19 [PDF]

Human Vaccines & Immunotherapeutics, 2020
SARS-CoV-2, the causative agent of COVID-19, has imposed a major public health threat, which needs effective therapeutics and vaccination strategies. Several potential candidate vaccines being rapidly developed are in clinical evaluation. Considering the crucial role of SARS-CoV-2 spike (S) glycoprotein in virus attachment, entry, and induction of ...
Yadav, Tushar, Srivastava, Nishant, Mishra, Gourav, Dhama, Kuldeep, Kumar, Swatantra, Puri, Bipin, Saxena, Shailendra K   +6 more
openaire   +3 more sources

Study on the Refusal of Vaccination against COVID-19 in Romania

, 2022
The refusal to be inoculated with the anti-COVID-19 vaccine by a part of the Romanian population becomes a barrier against controlling and stopping this particularly infectious virus.
Flavius-Cristian Mărcău, Sorin Purec, George Niculescu   +2 more
core   +1 more source

Motivators and barriers to COVID-19 vaccination of healthcare workers in Latvia

Frontiers in Psychology, 2022
This study aims to identify motivators and barriers regarding Coronavirus disease 2019 (COVID-19) vaccination among Latvian healthcare workers (HCWs). Data were collected from March to May 2021 using an online survey.
Sintija Lielsvagere-Endele, Jelena Kolesnikova, Elina Puzanova, Svetlana Timofejeva, Inga Millere   +4 more
doaj   +1 more source